ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $98 | +14.0% | 11,135 | -1.0% | 0.00% | 0.0% |
Q4 2022 | $86 | -99.9% | 11,249 | -20.6% | 0.00% | 0.0% |
Q3 2022 | $101,000 | -10.6% | 14,176 | +1.1% | 0.00% | 0.0% |
Q2 2022 | $113,000 | -57.0% | 14,015 | -25.9% | 0.00% | 0.0% |
Q1 2022 | $263,000 | -47.4% | 18,917 | +6.2% | 0.00% | -50.0% |
Q4 2021 | $500,000 | +1.0% | 17,805 | +22.3% | 0.00% | -33.3% |
Q3 2021 | $495,000 | +6.5% | 14,561 | +27.8% | 0.00% | 0.0% |
Q2 2021 | $465,000 | +19.5% | 11,390 | +18.0% | 0.00% | +50.0% |
Q1 2021 | $389,000 | -16.2% | 9,650 | +22.9% | 0.00% | -33.3% |
Q4 2020 | $464,000 | -35.1% | 7,855 | -46.6% | 0.00% | -40.0% |
Q3 2020 | $715,000 | – | 14,710 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |